TOBA

Femoropopliteal dissection repair using the Tack Endovascular System (6F, 3.5-6.0mm) following plain balloon angioplasty (POBA)

98.8%

Dissection Resolution

89.5%

12m K-M Freedom
from CD-TLR

76.4%

12m K-M Primary Patency

100%

Freedom from MAE
at 30 days

Conclusion:

Tack implant treatment of post-PTA dissection was safe, produced reasonable patency, and resulted in low rates of target lesion revascularization

DESCRIPTION: This multi-center, post-CE mark study evaluated the performance of the Tack Endovascular System® in subjects with post-angioplasty dissections resulting from percutaneous transluminal balloon angioplasty of superficial femoral or popliteal arteries. There were 138 patients enrolled at 13 European sites and twelve-month follow up has been completed.

Twelve-month results were presented in Leipzig, Germany at the LINC Conference by Dr. Marc Bosiers and subsequently published in the Journal of Vascular Surgery. Additionally, twenty-four month results from a single-center in Heide, Germany were presented in New York, New York at the VEITHsymposium® by Dr. Christian Wissgott.

The results supported Intact Vascular’s decision to conduct an Investigational Device Exemption trial, called TOBA II, which has completed enrollment and is currently in follow-up phase.

To learn more about this study, visit www.clinicaltrials.gov and search for NCT01663818.

PURPOSEBUILT. PRECISION REPAIR. PRESERVES OPTIONS.

Scroll to Top
Intact Vascular uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this.